Search - tctmd.com

Displaying 361 - 377 of 377

Sort: Relevancy | Date

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

Proximal Protection During Carotid Stenting Reduces Silent Infarcts

Jason Kahn

September 14, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

News Daily News

Better Clopidogrel Response Seen with Increased Smoking Levels

Jason Kahn

March 21, 2012

News Daily News

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

March 15, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Jason Kahn

March 05, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

Presentation TCT 2012

Assessment of Atherosclerosis at Coronary Bifurcations with Multislice Computed Tomography and Intravascular Ultrasound-Virtual Histology.

Presenter: Stella-Lida Papadopoulou, Salvatore Brugaletta, Hector M. Garcia-Garcia, Pim J. de Feyter, Patrick W. Serruys

January 03, 2012

News Daily News

BARI 2D: Older Age Makes No Difference in Therapies for Diabetics with Stable CAD

Leah Lawrence

August 09, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

Genetic Variant Predicts Revascularization, Disease Progression in Young MI Patients

July 13, 2011

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Leah Lawrence

May 26, 2011

News Daily News

CREST Subanalysis Stirs Controversy Regarding Possible Gender Differences

L.A. McKeown

May 10, 2011

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

Advertisement

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Proximal Protection During Carotid Stenting Reduces Silent Infarcts

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

Better Clopidogrel Response Seen with Increased Smoking Levels

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Assessment of Atherosclerosis at Coronary Bifurcations with Multislice Computed Tomography and Intravascular Ultrasound-Virtual Histology.

BARI 2D: Older Age Makes No Difference in Therapies for Diabetics with Stable CAD

Women Have Less Neointimal Hyperplasia Than Men With ZES

Genetic Variant Predicts Revascularization, Disease Progression in Young MI Patients

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

CREST Subanalysis Stirs Controversy Regarding Possible Gender Differences

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content